Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

NCT07447050 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Sarcoma
Gastric (Stomach) Cancer
Lung Cancer
Head and Neck Cancer
Colorectal Cancer
Ovarian Cancer
Liver Cancer
Genitourinary Cancer
Gynecologic Cancer

Interventions

DRUG: Riluzole
OTHER: Placebo

Sponsor

University of California, Irvine